Takeda has finished enrolling 20,100 children for a massive phase 3 dengue vaccine study.

After successfully shepherding a Zika vaccine candidate into the clinic before any other developer, Inovio Pharmaceuticals is amping up its efforts in HIV.

About 150 parents turned out to an anti-vaccine rally in Washington, D.C., on Friday. Not a new phenomenon, vaccine opposition may have gained steam with…

The NIH's Zika vaccine will move into phase 2 testing, officials said Friday. Despite the president's threats of spending cuts, this project is fully…

Prompts on electronic health records could make a big difference in flu vaccination rates.

Even as Pfizer’s vaccine outfit suffers a painful Prevnar 13 slowdown around the world, the group may soon get a boost in Europe.

A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.

​​​​​​​After taking a beating over a proposed Zika vaccine license from the U.S. Army, Sanofi is hitting back.